1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one
C24H24N2O2 — CID 155522075
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one
1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one (PubChem CID 155522075) has the molecular formula C24H24N2O2 and a molecular weight of 372.47 g/mol. Its IUPAC name is 1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one.
Molecular Properties
| Compound Name | 1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one |
|---|---|
| PubChem CID | 155522075 |
| Molecular Formula | C24H24N2O2 |
| Molecular Weight | 372.47 g/mol |
| Exact Mass | 372.18 |
| IUPAC Name | 1-[4-[(1R)-1-(dimethylamino)ethyl]phenyl]-2-hydroxy-4-methyl-5H-phenanthridin-6-one |
| SMILES | Cc1cc(O)c(-c2ccc([C@@H](C)N(C)C)cc2)c2c1[nH]c(=O)c1ccccc12 |
| InChI | InChI=1S/C24H24N2O2/c1-14-13-20(27)21(17-11-9-16(10-12-17)15(2)26(3)4)22-18-7-5-6-8-19(18)24(28)25-23(14)22/h5-13,15,27H,1-4H3,(H,25,28)/t15-/m1/s1 |
| InChIKey | KBQRGBIDUBDEQP-OAHLLOKOSA-N |
| XLogP | 4.98 |
| TPSA | 56.33 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 372.47 |
| LogP ≤ 5 | 4.98 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155522075 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.